COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the “Company”), today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market (“NASDAQ”). As previously disclosed, on March 17, 2016 the Company received a notification from NASDAQ indicating that, as a result of the Company not timely filing with the Securities […]